Wellnanopharmsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-08
Share capital
17,500.00 PLN
Registered address
ul. Jerzego Samuela Bandtkiego 19, 30-129 Kraków, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 462 days for 2023).

  • 2025not filed
  • 202420/10/2025
  • 202320/10/2025
  • 202216/06/2023
  • 202117/10/2022
  • 202007/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 49%
Voivodeship · Małopolskie28,204 / 46,033
Top 61%
Country · Poland307,945 / 495,850
Top 62%

Results vs industry

Revenue
This companyUSD 73.93kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -93.54kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 160.56kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 505.78kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Magdalena Anna Pieprzyk – President of the Management Board
Jerzy Grzybek – Attorney-in-fact

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Magdalena Anna Pieprzykage 40
140$1,890.8740%
Donald Piotr Piotrowskiage 65
35$472.7210%
Katarzyna Anastazja Sermak Jamróz
70$945.4320%
Łukasz Maciej Stupkaage 36
105$1,418.1530%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-05-01.

  • mBank
    67 1140 2004 0000 3802 7862 2050

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $1,269,896.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$32,989
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,128
Aid for research and development projects: industrial research
$686.4K

European Funds

ProjectEU co-financing
Development of a method for producing and using hydrogel as a carrier for oral delivery of drugs, peptides and proteins
$32,989
Development of a line of medical products based on nanogel, with properties ranging from skin care to therapeutic effects that soothe skin inflammation
$1.2M

Competitors

Name
MedappS.A.
SkinlabP.S.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.

Change history

DateEvent
2024-05-16Share capital increase
2021-02-12Name change
2020-10-14Address change
2020-09-30Name change
2019-03-08Entered in the register

FAQ

Last updated: 2026-04-11